The most common side effects of Pradaxa (dabigatran) include gastrointestinal problems like nausea, diarrhea, AND abdominal pain. Excessive bleeding is also a common side effect of Pradaxa. In some ...
Interim Results from RELY-ABLE®, the RE-LY® Extension Study, Provide Additional Clinical Evidence for the Safety of Pradaxa® (dabigatran etexilate mesylate) RIDGEFIELD, Conn., Nov. 7, 2012 -- ...
RIDGEFIELD, Conn., April 4, 2011 /PRNewswire/ --Two new retrospective subanalyses of the RE-LY® trial, involving Pradaxa® (dabigatran etexilate mesylate) capsules, suggested that the reduction in ...
RIDGEFIELD, Conn., Jan. 5, 2011 /PRNewswire/ -- Results of a post-hoc analysis of the RE-LY® trial among patients with non-valvular atrial fibrillation (NVAF) undergoing cardioversion, a treatment to ...
In the RE-LY ® (R andomized E valuation of L ong term anticoagulant therap Y) trial, Pradaxa ® 150mg bid demonstrated a 25% reduction in the risk of ischaemic strokes and a 74% reduction in the risk ...
Pradaxa is prescribed to reduce the risk of stroke and embolism, treat deep vein thrombosis and pulmonary embolism, prevent blood clots after hip replacement surgery, and treat venous thromboembolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results